Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mirtazapine for pruritus.

Mellar P Davis1, Jan L Frandsen, Declan Walsh

  • 1The Harry R. Horvitz Center for Palliative Medicine, Cleveland, OH, USA.

Journal of Pain and Symptom Management
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Journal of pain and symptom management·2026
Same author

Does the Edmonton Symptom Assessment Scale rule in or rule out anxiety and depression?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

MASCC score and neutropenic complications: what is the likelihood?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Intensive nursing intervention: what is the post treatment effect size on anxiety and depression?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Supportive oncology and the USA Cancer Moonshot: academic, clinical and operational opportunities.

BMJ supportive & palliative care·2026

Mirtazapine effectively reduced pruritus, a distressing symptom linked to cholestasis, renal failure, and cancers. This finding offers a potential new treatment avenue for patients experiencing severe itching.

Area of Science:

  • Medical research
  • Clinical case studies
  • Pharmacology

Background:

  • Pruritus is an uncommon yet severe symptom.
  • It is often associated with cholestasis, renal failure, and malignancies.
  • Current treatments include ondansetron and paroxetine.

Observation:

  • Four patients experiencing pruritus were treated with mirtazapine.
  • The patients' pruritus showed a positive response to the treatment.

Findings:

  • Mirtazapine demonstrated efficacy in alleviating pruritus in the observed patients.
  • This suggests mirtazapine as a potential therapeutic option for managing pruritus.

Implications:

  • The findings suggest a new treatment strategy for refractory pruritus.

Related Experiment Videos

  • Further clinical trials are warranted to confirm mirtazapine's effectiveness and safety profile.